DF
BIIB icon

Dunhill Financial’s Biogen BIIB Stock Holding History

Dunhill Financial’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.34K Buy
7
+2
+40% +$369 ﹤0.01% 901
2025
Q4 		$893 Buy
5
+2
+67% +$327 ﹤0.01% 849
2025
Q3 		$422 Sell
3
-1
-25% -$135 ﹤0.01% 868
2025
Q2 		$627 Sell
4
-6
-60% -$748 ﹤0.01% 832
2025
Q1 		$1.39K Sell
10
-142
-93% -$20.3K ﹤0.01% 786
2024
Q4 		$23.3K Buy
152
+50
+49% +$8.43K 0.01% 262
2024
Q3 		$19.8K Buy
102
+15
+17% +$3.14K 0.01% 278
2024
Q2 		$20.1K Buy
87
+76
+691% +$16.5K 0.01% 212
2024
Q1 		$2.31K Sell
11
-12
-52% -$2.81K ﹤0.01% 466
2023
Q4 		$5.94K Buy
+23
New +$5.65K 0.01% 274

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dunhill Financial's BIIB Position: Q1 2026 in Review

Dunhill Financial increased its Biogen (BIIB) stake by 40% in Q1 2026, buying an estimated $369 and bringing the position to 7 shares worth $1.34K. The position accounts for ﹤0.01% of the portfolio, ranked #901.

Dunhill Financial first reported a position in BIIB in Q4 2023 and has held it in 10 quarters since. The position peaked at $23.3K in Q4 2024. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Dunhill Financial held 7 shares of Biogen worth $1.34K as of Q1 2026.
  • Dunhill Financial bought 2 Biogen shares in Q1 2026, an estimated $369.
  • Biogen made up ﹤0.01% of Dunhill Financial's portfolio in Q1 2026, its #901 holding.
  • Dunhill Financial first reported a position in Biogen in Q4 2023 and has held it in 10 quarters since.
  • Dunhill Financial's Biogen position peaked at $23.3K in Q4 2024.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Dunhill Financial's 13F filing for Q1 2026, filed 6 May 2026.